Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Oncology

Subspecialties Bioinformatics

RNA: The Villain… and the Hero

| Jarret Glasscock

Big data is key to precision medicine, but presents a stumbling block for analysis – can machine learning help us overcome this hurdle?

Diagnostics Digital and computational pathology

Bitesized Breakthroughs

| Olivia Gaskill

We bring you the latest research in pathology and laboratory medicine – from machine learning to the genetic effects of the Chernobyl disaster

Diagnostics Analytical science

Aim for the Stars

| Michael Schubert

From mapping the universe to exploring immuno-oncology, celestial object-mapping algorithms are shining a light on secrets hidden in data

Diagnostics Analytical science

Testing for All

| Olivia Gaskill

A universal testing approach may help to detect hidden inherited mutations in colorectal cancer patients

Subspecialties Histology

Deep Blue Stain

| Dmitry A. Zinovkin

A new stain based on picro aniline, Ziehl’s fuchsin, and acetic acid offers a beautiful glimpse into the body

Diagnostics Genetics and epigenetics

Rethinking Risk Stratification for Acute Lymphoblastic Leukemia

| Olivia Gaskill

Integrated pediatric leukemia risk stratification and relapse prediction

Subspecialties Oncology

Fostering Collaboration and Sharing Know-How in Precision Medicine

| Sponsored by Thermo Fisher Scientific

Umberto Malapelle discusses his lab’s experience with onboarding precision medicine – and how other laboratories can follow in their footsteps

Diagnostics Histology

One Slide, All the Answers

| Sponsored by Bio-Techne

An innovative RNA in situ hybridization technology both localizes and quantifies RNA biomarkers to provide comprehensive diagnostic information

Diagnostics Genetics and epigenetics

KRAS G12C: The Mutation You Thought You Knew

| Sponsored by Amgen Oncology

Six reasons the KRAS G12C mutation matters

Inside the Lab Precision medicine

Personalized medicine – in vitro drug testing on primary cancer cells

| Sponsored by Tecan

Personalized treatments have the greatest potential to benefit cancer patients.


Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register